The Wayback Machine - https://web.archive.org/all/20060208150225/http://downlinebuilders.net:80/rusty/cetyl-myristoleate/medisure.htm

Cetyl Myristoleate Documentation

 

The strongest cetyl myristoleate product designed and Recomended by Dr Cochran for $21  

Do you have questions not answered on this site Rusty Ford

Home

My articles

Cetyl Myristoleate Science or Speculation

Cetyl Myristoleate separating fact from fiction

Listen to Dr Cochran

The Published Studies

Study Published in the Journal of Rheumatology

University of Nevada Study

A Randaomized Clinical Trial

Study by Advanced Medical Systems

New double blind study on CM for Fibromyalgia

San Diego Study

Journal Articles

LUBRICATE YOUR JOINTS By Charles Cochran

Townsen Letter for doctors & patients

Cetyl Myristoleate - A Unique Natural Compound Valuable in Arthritis Conditions

Quarterly Review of Natural Medicine

Double-Blinded Evidence Supports Cetyl Myristoleate

Natures Impact

Cetyl-Myristoleate: Remarkable relief from pain and inflammation

Designer fat for chronic pain

Total Health

A little clarity on cetyl myristoleate

Anti-arthritic and anti-aging qualities of Cetyl Myristoleate

Joe Weiders' Muscle and Fitness

CMO--a new cure for aching joints

Geritartics

NSAIDs associated with increased mortality

American Holistic Veterinary Medical Association

Cetyl Myristoleate for Arthritis and Tendonitis in Holistic Veterinary Medical Practice

Nukkles

                                  

 

 

Study by Advanced Medical Systems & Design, Ltd.

Advanced Medical Systems & Design, Ltd.  a two year field study on the effectiveness of their "natural nutritional compound", Cerasomal-cis-9-cetylmyristoleate (CMO), . The main thrust of this battery of tests was primarily focused on arthritis.

The study involved 888 female subjects ranging in age from 28 to 82, and 926 male subjects ranging in age from 29 - 74. All races and many ethnic backgrounds were represented. Age, gender, race, and ethnological background appeared to be irrelevant to patient response in this study. However, younger subjects seemed to respond earlier to the regimen program.

CMO was administered orally in the form of three capsules each morning and evening until the 96 capsules were consumed for 16 days. The subjects were examined on the eighth and sixteenth day for evaluation regarding pain, swelling and inflammation.

Encouraging results were found after testing the 1,814 subjects. The results showed that over 87% of the subjects had greater than 50% recovery and over 65% of those showed from 75% - 100% recovery following a sixteen day regimen. All types of arthritis were positively affected by CMO.

Studies showed improvement in all subjects except those who had suffered liver damage or those with digestive problems or disorders. Otherwise, every patient benefited.